Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Vavolizza RD, Petroni GR, Mauldin IS, et al. Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64). J Immunother Cancer 2022;10:e005424. doi: 10.1136/jitc-2022-005424
The author Rick Daniel Vavolizza has been updated to Rick D Vavolizza.